← Eichor
Condition: Allergy Pollen Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Allergy Pollen

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
NA · 1 location(s) · Inmunotek S.L. · NCT05532566Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04891237Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium
NA · 1 location(s) · prof. dr. Rik Schrijvers · NCT06714149Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis
Phase 2 · 1 location(s) · Beijing Tongren Hospital · NCT06300203Evaluation of the Efficacy of Oral Immunotherapy With Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospect
Phase 3 · 4 location(s) · University Hospital, Strasbourg, France · NCT06771791Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07309432Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preli
Phase 1 · 1 location(s) · Immunomic Therapeutics, Inc. · NCT07726147Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis
NA · 1 location(s) · Guang'anmen Hospital of China Academy of Chinese Medical Sci · NCT04815668Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic
Phase 2/Phase 3 · 1 location(s) · Shanghai Mabgeek Biotech.Co.Ltd · NCT06846385Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project
NA · 1 location(s) · Fundación de Investigación Biomédica - Hospital Universitari · NCT07419230A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Phase 3 · 1 location(s) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · NCT07154342Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NA · 6 location(s) · University of Melbourne · NCT07055542The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy
Phase N/A · 2 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04544774PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis
Phase 2 · 1 location(s) · Kazakh National Agrarian University · NCT07563439GRASS (Grass MATA MPL Real-world Assessment Study)
Phase N/A · 1 location(s) · Allergy Therapeutics · NCT07412990A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With S
Phase 2 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07091357A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Und
Phase 2 · 1 location(s) · Alixer Nexgen Therapeutics Limited · NCT07219849Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis
Phase 2 · 30 location(s) · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07398859
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.